The 2025 Medicare Physician Fee Schedule (PFS) Proposed Rule has arrived delivering with it new policy and provision changes for next year that will have
What criteria must be met when using 96374 with 96375?
What codes do we report for monoclonal antibody Beyfortus™?
What factors should be documented when determining whether an antineoplastic agent is being administered for cancer or another cause?
From a claims perspective, what are some red flags when reviewing infusion and injection claims?
When do we assign code 0631T?
Why can’t we code 95180 (rapid desensitization) and chemotherapy drug administration codes together when we perform carboplatin desensitization?
What is the difference between white bagging and brown bagging regarding patient-supplied drugs?
Do we use 0493T to report transcutaneous oxyhemoglobin measurement of a lower extremity wound by near-infrared spectroscopy in 2024?
For noninvasive physiologic studies when both upper and the lower extremity arteries are studied, what codes do we report?
We have a patient who received three hours of IV hydration. During that time, the patient received two different drugs by intravenous push. Can the entire 3 hours of IV hydration be coded with the intravenous push injections?
Subscribe to receive our News, Insights, and Compliance Question of the Week articles delivered right to your inbox.
Subscribe to receive our News, Insights, and Compliance Question of the Week delivered right to your inbox.
Address: 5874 Blackshire Path, #13, Inver Grove Heights, MN 55076
Phone: (800) 252-1578
Email: support@medlearnmedia.com
Hours: 9am – 5pm CT
Copyright © 2024 MedLearn Publishing. Powered by MedLearn Media.
